
    
      A Randomized, Double-Blind, Placebo-Controlled, Parallel Group, Multicenter Study to Evaluate
      the Efficacy and Safety of GW685698X 200mcg Twice Daily, GW685698X 200mcg and 400mcg Once
      Daily in the Morning, and GW685698X 200mcg and 400mcg Once Daily in the Evening Compared with
      Placebo for 8 Weeks in Adolescent and Adult Subjects (12 Years of Age and Older) with
      Persistent Asthma.
    
  